en
Scientific article
English

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

Published inAnnals of the Rheumatic Diseases, vol. 78, no. 7, p. 979-987
Publication date2019
Abstract

To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical practice.

Keywords
  • Lung fibrosis
  • Rituximab
  • Skin fibrosis
  • Systemic sclerosis
Citation (ISO format)
ELHAI, Muriel et al. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. In: Annals of the Rheumatic Diseases, 2019, vol. 78, n° 7, p. 979–987. doi: 10.1136/annrheumdis-2018-214816
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0003-4967
208views
0downloads

Technical informations

Creation09/02/2019 4:02:00 PM
First validation09/02/2019 4:02:00 PM
Update time03/15/2023 9:14:58 PM
Status update03/15/2023 9:14:56 PM
Last indexation01/17/2024 9:11:42 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack